Evidence map›Paper›PMID 36145412›Full record

ArticlePathogens (Basel, Switzerland)2022

Protective Effect of

Maja Starc, Miha Lučovnik, Petra Eržen Vrlič, Samo Jeverica

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Modulation of group BInfection and immunity · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Group BFrontiers in cellular and infection microbiology · 2024
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Maja StarcDepartment of Obstetrics and Gynecology, General Hospital Slovenj Gradec, 2380 Slovenj Gradec, Slovenia.
Miha LučovnikDepartment of Perinatology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Petra Eržen VrličDepartment of Obstetrics and Gynecology, Community Health Center Ljubljana, 1000 Ljubljana, Slovenia.
Samo JevericaCenter for Medical Microbiology, National Laboratory of Health, Environment and Food, 2000 Maribor, Slovenia.ORCID 0000-0002-8373-8080
Community Health Centre Ljubljana · SILjubljana University Medical Centre · SINational Laboratory of Health, Environment and Food · SIŠolski center Slovenj Gradec · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A normal vaginal microbiota may protect the vaginal mucosa from colonization by potentially pathogenic bacteria, including group B streptococci (GBS). The aim of this study was to investigate the association between colonization with GBS and the presence of specific vaginal microbiota isolated from vaginal swabs in the third trimester of pregnancy. Methods: A semiquantitative culture of 1860 vaginal swabs from consecutive pregnant women in their third trimester was analyzed. The dominant bacteria, including lactobacilli, were identified using MALDI-TOF mass spectrometry. An enrichment culture for GBS was performed on the swabs. GBS colonization correlated with the bacteria isolated at the same time. Results: Lactobacilluscrispatus was isolated in 27.5% of the cultures, followed by L. jensenii (13.9%), L. gasseri (12.6%), and L. iners (10.1%). The presence of lactobacilli as a group, and of L. crispatus, inversely correlated with GBS colonization (OR = 0.44 and OR = 0.5, respectively; both with p < 0.001). Other microorganisms, including Gardnerella vaginalis, mixed aerobic bacteria and yeasts, were not associated with GBS colonization. Conclusions: Lactobacilli, especially L. crispatus, may prevent GBS colonization in pregnancy. Maintaining a normal vaginal microbiota could be an effective method for the antibiotic-free prevention of invasive GBS infections in neonates.

Indexed as

colonizationgroup B Streptococcusinvasive GBS infectionsLactobacillus crispatusneonatespregnant womensemiquantitative culturevaginal microbiota

Identifiers

PMID36145412
PMCPMC9506259
OpenAlexW4293769584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.